ROBERT RIDGEWAY: Open Payments
NPI 1942616750 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,883 in 93 payments from 19 companies in 2025. Trend: 2023 $1,654 · 2024 $2,916 · 2025 $2,883
Food & beverage: $2,690Education: $193
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $461 |
| PFIZER INC. | 14 | $414 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $408 |
| Novartis Pharmaceuticals Corporation | 5 | $287 |
| Janssen Biotech, Inc. | 8 | $209 |
| Lilly USA, LLC | 5 | $183 |
| Incyte Corporation | 5 | $178 |
| Regeneron Healthcare Solutions, Inc. | 1 | $123 |
| Amgen Inc. | 5 | $117 |
| LEO Pharma Inc. | 4 | $101 |
Products named: CIBINQO, DUPIXENT, RINVOQ, TREMFYA, SKYRIZI, Opzelura, EBGLYSS, ILUMYA.
Industry payments across SC — which companies pay providers there.
